Gustave Roussy is the first leader cancer-research hospital in Europe and ranked among the top 5 best specialized hospitals in the world. It is a centre for high quality patient care, research and teaching. It is highly-known for the treatment of: skin cancers like melanoma, breast cancer, and lung cancer.

There are 457 beds in Institut Gustave Roussy; Unite D'Hematologie.

During the past decade, Institut Gustave Roussy; Unite D'Hematologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Gustave Roussy; Unite D'Hematologie" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institut Gustave Roussy; Unite D'Hematologie" are "B-cell Lymphoma" (1 trials), "Colorectal Neoplasms" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Lymphocytic Leukemia, Chronic" (1 trials). Many other conditions were trialed in "Institut Gustave Roussy; Unite D'Hematologie" in a lesser frequency.

Most popular intervention types in "Institut Gustave Roussy; Unite D'Hematologie" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "ABI-007" (1 trials), "Bevacizumab" (1 trials), "CHOP" (1 trials) and "Chlorambucil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Gustave Roussy; Unite D'Hematologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Institut Gustave Roussy; Unite D'Hematologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut Gustave Roussy; Unite D'Hematologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Gustave Roussy; Unite D'Hematologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".